OBJECTIVE: To analyze the spectrum of neurological manifestations in children hospitalized with pandemic influenza A H1N1 virus of 2009 (pH1N1). DESIGN: Retrospective case series of children hospitalized from May 1, 2009, through November 30, 2009. SETTING: Tertiary-care children's hospital in Colorado. PATIENTS: All hospitalized patients with pH1N1 with neurological consult or diagnosis, lumbar puncture, electroencephalogram, or neuroimaging were selected as suspected cases. These were systematically reviewed and selected for final analysis if confirmed by pre-established definitions as a neurological complication. RESULTS: Of 307 children with pH1N1, 59 were selected as having suspected cases of neurological complications. Twenty-three children were confirmed to have a neurological complication. Of these 23, 15 (65%) required intensive care monitoring. The median length of stay was 4 days. Seventeen (74%) had a preexisting neurological diagnosis. The most common manifestation was seizure with underlying neurological disease (in 62% of cases) followed by encephalopathy with or without neuroimaging changes (in 26% of cases). Results from a lumbar puncture showed elevated protein levels in 3 of 6 patients but no significant pleocytosis. Seven of the 9 electroencephalograms showed diffuse slowing, and findings from magnetic resonance imaging were abnormal in 5 of 6 children. Deaths occurred in 13% of patients, and short-term disability in 22%. CONCLUSIONS: Children infected with pH1N1 presented with a wide spectrum of neurological manifestations, which occurred primarily in individuals with preexisting neurological conditions. These individuals had a severe disease course, evidenced by need for intensive care services and relatively high rates of mortality or neurological disability. Children with underlying neurological conditions should be particularly targeted for influenza prevention and aggressive supportive treatment at the onset of influenzalike symptoms.
OBJECTIVE: To analyze the spectrum of neurological manifestations in children hospitalized with pandemic influenzaA H1N1 virus of 2009 (pH1N1). DESIGN: Retrospective case series of children hospitalized from May 1, 2009, through November 30, 2009. SETTING: Tertiary-care children's hospital in Colorado. PATIENTS: All hospitalized patients with pH1N1 with neurological consult or diagnosis, lumbar puncture, electroencephalogram, or neuroimaging were selected as suspected cases. These were systematically reviewed and selected for final analysis if confirmed by pre-established definitions as a neurological complication. RESULTS: Of 307 children with pH1N1, 59 were selected as having suspected cases of neurological complications. Twenty-three children were confirmed to have a neurological complication. Of these 23, 15 (65%) required intensive care monitoring. The median length of stay was 4 days. Seventeen (74%) had a preexisting neurological diagnosis. The most common manifestation was seizure with underlying neurological disease (in 62% of cases) followed by encephalopathy with or without neuroimaging changes (in 26% of cases). Results from a lumbar puncture showed elevated protein levels in 3 of 6 patients but no significant pleocytosis. Seven of the 9 electroencephalograms showed diffuse slowing, and findings from magnetic resonance imaging were abnormal in 5 of 6 children. Deaths occurred in 13% of patients, and short-term disability in 22%. CONCLUSIONS:Children infected with pH1N1 presented with a wide spectrum of neurological manifestations, which occurred primarily in individuals with preexisting neurological conditions. These individuals had a severe disease course, evidenced by need for intensive care services and relatively high rates of mortality or neurological disability. Children with underlying neurological conditions should be particularly targeted for influenza prevention and aggressive supportive treatment at the onset of influenzalike symptoms.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Jason G Newland; V Matt Laurich; Anna W Rosenquist; Kateri Heydon; Daniel J Licht; Ron Keren; Theoklis E Zaoutis; Barbara Watson; Richard L Hodinka; Susan E Coffin Journal: J Pediatr Date: 2007-03 Impact factor: 4.406
Authors: Christine C Ginocchio; Frank Zhang; Ryhana Manji; Suman Arora; Mark Bornfreund; Leon Falk; Madhavi Lotlikar; Margaret Kowerska; George Becker; Diamanto Korologos; Marcella de Geronimo; James M Crawford Journal: J Clin Virol Date: 2009-06-16 Impact factor: 3.168
Authors: Navin K Vij; Christopher C Stryker; Frank P Esper; Michael R Jacobs; Blanca E Gonzalez Journal: Pediatrics Date: 2011-10-03 Impact factor: 7.124
Authors: Gulam Khandaker; Yvonne Zurynski; Jim Buttery; Helen Marshall; Peter C Richmond; Russell C Dale; Jenny Royle; Michael Gold; Tom Snelling; Bruce Whitehead; Cheryl Jones; Leon Heron; Mary McCaskill; Kristine Macartney; Elizabeth J Elliott; Robert Booy Journal: Neurology Date: 2012-09-19 Impact factor: 9.910
Authors: Asha Prerna; Jocelyn Y X Lim; Natalie W H Tan; Mas Suhaila Isa; Helen May-Lin Oh; Norazieda Yassin; Chian-Yong Low; Derrick W S Chan; Chia-Yin Chong; Yee-Sin Leo; Angela Li-Ping Chow; Paul Ananth Tambyah; Kevin Tan Journal: J Neurovirol Date: 2015-04-28 Impact factor: 2.643
Authors: James W Antoon; Matt Hall; Alison Herndon; David P Johnson; Charlotte M Brown; Whitney L Browning; Todd A Florin; Leigh M Howard; Carlos G Grijalva; Derek J Williams Journal: J Pediatr Date: 2021-07-01 Impact factor: 4.406